No differences were observed in the number of positive hematological tumor cell lines in which CXCL10, CXCL9, MICA and MICB expression was up-regulated (FC ≥2) by all investigated DHAs treatments (Supplementary Tables 19–22). This evidence concerns the gene CXCL10 and hematopoietic and lymphoid cell neoplasm.